Building a future where the investment system delivers better health for everyone
Economic and health inequality go hand-in-hand. The Covid-19 pandemic has shone a spotlight on this and demonstrated how vital a healthy population is for economic prosperity. For too long health factors – and related social challenges – have taken a back seat in investment decisions. We have an opportunity to change this.
We’re building a new programme, Long-term Investors in People’s Health (LIPH), to support the investment system to consider health and related social factors within their decision-making processes.
Why health matters for investors?
Better health could add $12 trillion to global GDP in 2040 and see 120 million full-time workers joining the global workforce.
70 million workdays are lost each year due to mental health problems in the UK, while employers investing in mental health saw a return of £5 for every £1 spent.
Obesity related disease costs UK business £27 billion per year. 73% of consumers are willing to pay more for healthy products.
There is both an ethical and financial imperative for investors to act. As regulation begins to catch-up with public demand for companies to support them to live healthier lives, companies are at increasing risk if they aren’t ahead of the curve. Investors can support and accelerate this transition.
Through LIPH, we’ll help investors to identify and prioritise health-related factors and build a movement of leading investors from all over the world to improve population health.
What does LIPH aim to do?
We’ll work with experts from across public health, academia, government and the private sector to set a vision for an investment system that values people’s health;
We’ll identify key health-releated topics for investors to integrate into investment strategies, and build an investor coalition to drive change across key health areas;
We’ll work to scale the programme to become the recognised global voice on stewardship and health.
What does LIPH aim to do?
- We’ll work with experts from across public health, academia, government and the private sector to set a vision for an investment system that values people’s health;
- Identify key health-releated topics for investors to integrate into investment strategies, and build an investor coalition to drive change across key health areas;
- We’ll work to scale the programme and the key health topics covered to become the recognised global voice on stewardship and health.
See more of ShareAction’s work to improve health
Steering Group members
Kieron Boyle is Chief Executive of Guy’s and St Thomas’ Foundation, one of the world’s oldest health endowments. He is a leading voice on urban health. He previously led the UK government’s work on impact investment. Kieron is on the Boards of the Design Council and Big Society Capital.
The Right Honourable Alan Milburn was an MP between 1992 and 2010 and served in Prime Minister Tony Blair’s government as Chief Secretary to the Treasury, Secretary of State for Health and Chancellor of the Duchy of Lancaster. In his post-politics life he has a successful business career advising corporate and government clients across the world. He is Chancellor of Lancaster University, Chair of the Social Mobility Foundation and a former Chair of the Commission on Social Mobility.
Alvise Munari is the Global Head of Client Coverage at MSCI and a member of MSCI’s Executive Committee. He oversees MSCI’s client business globally across all products and services. Before joining MSCI, he spent 20 years in the banking industry most recently at Morgan Stanley.
Catherine Howarth joined ShareAction as Chief Executive in 2008. ShareAction coordinates civil society activism to promote responsible investment across Europe. She is a member of HM Treasury’s asset management taskforce. She is a board member of the Scott Trust, owner of The Guardian, serving on the Scott Trust’s investment committee. Catherine was recognised by the World Economic Forum as a Young Global Leader in 2014.
Dr Jennifer Dixon is chief executive of The Health Foundation, an independently endowed foundation which seeks to improve health and health care for the people of the UK. With a background in medicine and research, Jennifer is a fellow of the Royal College of Physicians, and a fellow of the Academy of Medical Sciences. She was awarded a CBE for services to public health in 2013, and a Doctor of Science from Bristol University in 2016.
Professor Sir Michael Marmot is Director of the Institute of Health Equity (UCL Department of Epidemiology & Public Health). He is the author of The Health Gap: the challenge of an unequal world. Professor Marmot is the Advisor to the WHO Director-General, on social determinants of health. He conducted the Strategic Review of Health Inequalities in England post 2010, which published its report ‘Fair Society, Healthy Lives’ in February 2010. This was followed by Health Equity in England: Marmot Review 10 Years On and Build Back Fairer: the COVID-19 Marmot Review.
Michael Traill AM was founding CEO of Social Ventures Australia from 2002-14, after 15 years as a co-founder and Executive Director of Macquarie Group’s private equity arm. He currently holds a range of roles including as Chair of the A$4b Paul Ramsay Foundation; Executive Director of For Purpose Investment Partners and Investment Committee Chair of Sunsuper. He is a director of Sunsuper, MH Carnegie & Co, Hearts & Minds Investments and Australian Philanthropic Services. Michael is also Chair of the Federal Government Social Impact Investing Task Force and Adjunct Professor at the Centre for Social Impact at UNSW. He is the author of ‘Jumping Ship – From the world of corporate Australia to the heart of social investment’ which won the Ashurst Business Literature Prize. He holds a BA (Hons) from the University of Melbourne and an MBA from Harvard University.
Dr Rachel Melsom, MBBS consults on the interface of healthcare and investor-led finance. Collaborating with investors to deliver improved health outcomes whilst also meeting finance sector objectives, reframing financial objectives utilising innovative thinking and re-positioning to deliver the required outcomes and effect measurable change. She is also an NHS doctor.
A member of the ABI’s Executive Team, Yvonne Braun directs the ABI’s work on long-term savings. She also leads the ABI’s D&I programme, and the sector’s charitable £100m Covid-19 Support Fund. Yvonne is a member of the Government’s Industry Steering Group for the Pensions Dashboards Project, and a former trustee of Asthma UK.